000891321 000__ 03730cam\a2200505Ii\4500
000891321 001__ 891321
000891321 005__ 20230306150040.0
000891321 006__ m\\\\\o\\d\\\\\\\\
000891321 007__ cr\cn\nnnunnun
000891321 008__ 190605s2019\\\\sz\\\\\\ob\\\\001\0\eng\d
000891321 019__ $$a1107172223
000891321 020__ $$a9783030167158$$q(electronic book)
000891321 020__ $$a3030167151$$q(electronic book)
000891321 020__ $$z9783030167134
000891321 0247_ $$a10.1007/978-3-030-16715-8$$2doi
000891321 035__ $$aSP(OCoLC)on1103605874
000891321 035__ $$aSP(OCoLC)1103605874$$z(OCoLC)1107172223
000891321 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dEBLCP$$dUKMGB$$dUPM$$dGW5XE$$dOCLCF
000891321 049__ $$aISEA
000891321 050_4 $$aRC388.5
000891321 08204 $$a362.196120072$$223
000891321 24500 $$aTherapeutic intranasal delivery for stroke and neurological disorders /$$cJun Chen, Jiang Wang, Ling Wei, John H. Zhang, editors.
000891321 264_1 $$aCham :$$bSpringer,$$c2019.
000891321 300__ $$a1 online resource.
000891321 336__ $$atext$$btxt$$2rdacontent
000891321 337__ $$acomputer$$bc$$2rdamedia
000891321 338__ $$aonline resource$$bcr$$2rdacarrier
000891321 347__ $$atext file$$bPDF$$2rda
000891321 4901_ $$aSpringer series in translational stroke research
000891321 504__ $$aIncludes bibliographical references and index.
000891321 5050_ $$aPreface -- Transnasal Induction of Therapeutic Hypothermia for Neuroprotection -- Hypoxia-Primed Stem Cell Transplantation in Stroke -- Therapeutic potential of intranasal drug delivery in preclinical studies of ischemic stroke and intracerebral hemorrhage -- Intranasal Drug Delivery after Intracerebral Hemorrhage -- Intranasal Treatment in Subarachnoid Hemorrhage -- Intranasal Delivery of Therapeutic Peptides for Treatment of Ischemic Brain Injury -- Intranasal delivering method in the treatment of ischemic stroke -- Intranasal Delivery of Drugs for Ischemic Stroke Treatment: Targeting IL-17A -- Intranasal tPA application for axonal remodeling in rodent stroke and traumatic brain injury models -- Therapeutic Intranasal Delivery for Alzheimer's disease -- Combination therapy of intranasal IGF-1 and hypothermia -- Intranasal Medication Delivery in Children for Brain Disorders -- Index.
000891321 506__ $$aAccess limited to authorized users.
000891321 520__ $$aThe blood-brain-barrier prevented harmful materials entering the brain and in the meantime is a barricade to therapeutic drug delivery. Intranasal drug delivery to circumvent blood-brain-barrier was developed in the past, to take advantages of a secret passage from the olfactory epithelium into the brain-bypassing the tight junctions that encapsulated the brain from blood circulation. This timely publication of Therapeutic Intranasal Delivery for Stroke and Neurological Disorders presented some of the latest advances in intranasal delivery research, including transnasal hypothermia induction, stem cell intranasal transplantation, intranasal drug delivery in ischemic and hemorrhagic models, intranasal peptides delivery, intranasal tPA application in adults and children. Editors Jun Chen, Jian Wang, Ling Wei and John Zhang are professors from University of Pittsburgh, Johns Hopkins University, Emory University and Loma Linda University in USA.
000891321 588__ $$aOnline resource; title from PDF title page (viewed June 6, 2019)
000891321 650_0 $$aCerebrovascular disease$$xResearch.
000891321 7001_ $$aChen, Jun$$c(Professor of neurology and pharmacology),$$eeditor.
000891321 7001_ $$aWang, Jian,$$eeditor.
000891321 7001_ $$aWei, Ling,$$eeditor.
000891321 7001_ $$aZhang, J. H.$$q(John H.),$$eeditor.
000891321 77608 $$iPrint version: $$z9783030167134
000891321 830_0 $$aSpringer series in translational stroke research.
000891321 852__ $$bebk
000891321 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-030-16715-8$$zOnline Access$$91397441.1
000891321 909CO $$ooai:library.usi.edu:891321$$pGLOBAL_SET
000891321 980__ $$aEBOOK
000891321 980__ $$aBIB
000891321 982__ $$aEbook
000891321 983__ $$aOnline
000891321 994__ $$a92$$bISE